Alexander Koers

1.1k total citations
17 papers, 548 citations indexed

About

Alexander Koers is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, Alexander Koers has authored 17 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Immunology and 6 papers in Oncology. Recurrent topics in Alexander Koers's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Immunotherapy and Immune Responses (5 papers). Alexander Koers is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Immunotherapy and Immune Responses (5 papers). Alexander Koers collaborates with scholars based in United Kingdom, Germany and Australia. Alexander Koers's co-authors include Philip J. Blower, Gregory Mullen, Kavitha Sunassee, Richard Tavaré, David J. Berry, Daniel Gliddon, Yongmin Ma, Neil Brewis, James R. Ballinger and Robert C. Hider and has published in prestigious journals such as PLoS ONE, Cancer Research and Chemical Communications.

In The Last Decade

Alexander Koers

17 papers receiving 540 citations

Peers

Countries citing papers authored by Alexander Koers

Since Specialization

Citations

This map shows the geographic impact of Alexander Koers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Koers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Koers more than expected).

Fields of papers citing papers by Alexander Koers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Koers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Koers. The network helps show where Alexander Koers may publish in the future.

Co-authorship network of co-authors of Alexander Koers

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Koers. A scholar is included among the top collaborators of Alexander Koers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Koers. Alexander Koers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart 2021 ·OncoImmunology ·Francis Man, Alexander Koers, Panagiotis Karagiannis, Debra H. Josephs, Heather J. Bax, Amy E. Gilbert, Tihomir Dodev, Silvia Mele, Giulia Chiaruttini, Silvia Crescioli, Jitesh Chauhan, (unknown), Margaret S. Cooper, James Spicer, Sophia N. Karagiannis, Philip J. Blower	2
2	FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity 2020 ·Clinical Cancer Research ·Matthew Kraman, Mustapha Faroudi, (unknown), (unknown), Daniel Gliddon, (unknown), Alexander Koers, Mateusz Wydro, Sarah Batey, (unknown), Lesley Young, (unknown), Jacqueline Doody, Michelle Morrow, Neil Brewis	82
3	Noninvasive MRI Native T1 Mapping Detects Response to MYCN -targeted Therapies in the Th- MYCN Model of Neuroblastoma 2020 ·Cancer Research ·(unknown), Evon Poon, Matthew Clarke, Neil P. Jerome, Jessica K.R. Boult, Matthew Blackledge, Fernando Carceller, Alexander Koers, Giuseppe Barone, Andrew D.J. Pearson, Lucas Moreno, John Anderson, Neil J. Sebire, Kieran McHugh, Dow‐Mu Koh, Louis Chesler, Yinyin Yuan, Simon P. Robinson, Yann Jamin	21
4	FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Exhibits Low Toxicity and Antitumor Activity in Colorectal Cancer Models 2020 ·Clinical Cancer Research ·Matthew A. Lakins, Alexander Koers, (unknown), Jose Muñoz-Olaya, Robert Hughes, Emma Goodman, (unknown), (unknown), Sarah Batey, Daniel Gliddon, (unknown), Neil Brewis	44
5	Abstract 4547: Clustering CD137 via cell-expressed PD-L1 crosslinking avoided Fc-mediated agonism and resulted in safe and potent conditional lymphocyte activation 2020 ·Cancer Research ·Matthew A. Lakins, Alexander Koers, (unknown), Robert Hughes, (unknown), Mateusz Wydro, Cristian Grădinaru, Sarah Batey, Daniel Gliddon, Michelle Morrow, Neil Brewis	1
6	SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma 2019 ·Endocrine Related Cancer ·Gabriela Carreno, Jessica K.R. Boult, John Apps, José Mario González-Meljem, Scott Haston, Romain Guiho, Christina Stache, Laura S. Danielson, Alexander Koers, L Smith, Alex Virasami, Leonidas Panousopoulos, Michael Buchfelder, Thomas S. Jacques, Louis Chesler, Simon P. Robinson, Juan Pedro Martı́nez-Barberá	24
7	Abstract 2399: LAG-3/PD-L1 mAb2 can overcome PD-L1-mediated compensatory upregulation of LAG-3 induced by single-agent checkpoint blockade 2019 ·Cancer Research ·Mustapha Faroudi, Matthew Kraman, (unknown), (unknown), Daniel Gliddon, (unknown), (unknown), Alexander Koers, Mateusz Wydro, Michelle Morrow, Neil Brewis	2
8	Abstract 1540: FS222 mAb², a bispecific conditional agonist antibody targeting CD137 and PD-L1, induces potent lymphocyte activation and has a favorable safety profile 2019 ·Immunology ·Matthew A. Lakins, Alexander Koers, (unknown), (unknown), D. H. Jones, (unknown), (unknown), (unknown), Mateusz Wydro, Cristian Grădinaru, (unknown), Sarah Batey, Daniel Gliddon, Michael Davies, Michelle Morrow, (unknown), Neil Brewis	1
9	Abstract 1540: FS222 mAb2, a bispecific conditional agonist antibody targeting CD137 and PD-L1, induces potent lymphocyte activation and has a favorable safety profile 2019 ·Cancer Research ·Matthew A. Lakins, Alexander Koers, (unknown), (unknown), Daniel B. Jones, (unknown), (unknown), (unknown), Mateusz Wydro, Cristian Grădinaru, (unknown), Sarah Batey, Daniel Gliddon, Michael A. Davies, Michelle Morrow, (unknown), Neil Brewis	1
10	Abstract 2719: Dual blockade of PD-L1 and LAG-3 with FS118, a unique bispecific antibody, induces CD8+ T-cell activation and modulates the tumor microenvironment to promote antitumor immune responses 2018 ·Cancer Research ·Matthew Kraman, (unknown), (unknown), Katy L. Everett, (unknown), Mustapha Faroudi, Mateusz Wydro, Alexander Koers, Lesley Young, Daniel Gliddon, Michelle Morrow, Jacqueline Doody, (unknown), Neil Brewis	13
11	Preclinical transgenic and patient‐derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngioma 2017 ·Brain Pathology ·Jessica K.R. Boult, John Apps, Annett Hölsken, J. Ciaran Hutchinson, Gabriela Carreno, Laura S. Danielson, Laura Smith, Tobias Bäuerle, Rolf Buslei, Michael Buchfelder, Alex Virasami, Alexander Koers, Owen J. Arthurs, Thomas S. Jacques, Louis Chesler, Juan Pedro Martı́nez-Barberá, Simon P. Robinson	14
12	p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance 2016 ·Cancer Research ·Orli Yogev, Karen Barker, (unknown), Gilberto S. Almeida, Albert Hallsworth, Laura Smith, Yann Jamin, Ruth Ruddle, Alexander Koers, Hannah Webber, Florence I. Raynaud, Sergey Popov, Chris Jones, Kevin Petrie, Simon P. Robinson, Hector C. Keun, Louis Chesler	32
13	Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application 2011 ·Cancer Immunology Immunotherapy ·Sophia N. Karagiannis, Debra H. Josephs, Panagiotis Karagiannis, Amy E. Gilbert, Louise Saul, Sarah Maria Rudman, Tihomir Dodev, Alexander Koers, Philip J. Blower, Christopher J. Corrigan, Andrew J. Beavil, James Spicer, Frank O. Nestlé, Hannah J. Gould	46
14	In Vivo SPECT Reporter Gene Imaging of Regulatory T Cells 2011 ·PLoS ONE ·Ehsan Sharif‐Paghaleh, Kavitha Sunassee, Richard Tavaré, Kulachelvy Ratnasothy, Alexander Koers, Niwa Ali, Rowa Y. Alhabbab, Philip J. Blower, Robert I. Lechler, Lesley A. Smyth, Gregory Mullen, Giovanna Lombardi	44
15	Monitoring the Systemic Human Memory B Cell Compartment of Melanoma Patients for Anti-Tumor IgG Antibodies 2011 ·PLoS ONE ·Amy E. Gilbert, Panagiotis Karagiannis, Tihomir Dodev, Alexander Koers, Katie E. Lacy, Debra H. Josephs, Pooja Takhar, Jenny L. C. Geh, Ciaran Healy, Mark Harries, K. Acland, Sarah Maria Rudman, Rebecca L. Beavil, Philip J. Blower, Andrew J. Beavil, Hannah J. Gould, James Spicer, Frank O. Nestlé, Sophia N. Karagiannis	64
16	Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands 2011 ·Chemical Communications ·David J. Berry, Yongmin Ma, James R. Ballinger, Richard Tavaré, Alexander Koers, Kavitha Sunassee, Tao Zhou, (unknown), Gregory Mullen, Robert C. Hider, Philip J. Blower	110
17	Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein 2010 ·European Journal of Nuclear Medicine and Molecular Imaging ·Florian Kampmeier, Judith Niesen, Alexander Koers, (unknown), Andreas Brecht, Rainer Fischer, Fabian Kießling, Stefan Barth, Theo Thepen	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact